Next Article in Journal

Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity

Next Article in Special Issue

Enhanced Immune Response Against Echinococcus Granulosus Through a CTLA-4/B7 Affinity-Based Vaccine

Previous Article in Journal

Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1

Previous Article in Special Issue

Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Vaccines 2024, 12(11), 1237; https://doi.org/10.3390/vaccines12111237

Action	Date	Notes	Link
article pdf uploaded.	30 October 2024 15:27 CET	Version of Record	https://www.mdpi.com/2076-393X/12/11/1237/pdf-vor
article xml file uploaded	31 October 2024 07:49 CET	Original file	-
article xml uploaded.	31 October 2024 07:49 CET	Update	https://www.mdpi.com/2076-393X/12/11/1237/xml
article pdf uploaded.	31 October 2024 07:49 CET	Updated version of record	https://www.mdpi.com/2076-393X/12/11/1237/pdf
article html file updated	31 October 2024 07:51 CET	Original file	https://www.mdpi.com/2076-393X/12/11/1237/html

Back to TopTop